Medtech Temporaries Inc is categorized under Temporary Employment Contractors in Philadelphia, PA and active since 2001.
Medtech Temporaries Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Temporary Employment Contractors business, which does work in the B2B market, and is classified as a Temporary Employment Contractors, under code number 561320 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Singer at the company’s single location by writing to 325 Chestnut St # 903, Philadelphia, Pennsylvania PA 19106 or by phoning (215) 592-8500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medtech Temporaries Inc |
| Contact Person: | Jeffrey Singer |
| Address: | 325 Chestnut St # 903, Philadelphia, Pennsylvania 19106 |
| Phone Number: | (215) 592-8500 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Temporary Employment Contractors |
| SIC Code: | 7363 |
| NAICS Code: | 561320 |
| Share This Business: |
Medtech Temporaries Inc was started in 2001 to provide professional Temporary Employment Contractors under the SIC code 7363 and NAICS code 561320. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jeffrey Singer for inquiries that concern Medtech Temporaries Inc by calling the company number (215) 592-8500, as your correspondence is most welcome. Additionally, the physical location of the single location of Medtech Temporaries Inc can be found at the coordinates as well as the street address 325 Chestnut St # 903 in Philadelphia, Pennsylvania 19106.
For its online presence, you may visit Medtech Temporaries Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.